Oral OTC Analgesics Market by Product Type and Distribution Channel- Global Industry Analysis & Forecast to 2027

Published On : December 2020 Pages : 154 Category: Pharma & Healthcare Report Code : HC1214163

Oral OTC Analgesics Market By Product Type (Acetaminophen (TYLENOL), Salicylates, Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)- Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Oral OTC Analgesics Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Oral OTC Analgesics work on the body’s peripheral and central nervous systems to block or decrease sensitivity to pain. Others act by inhibiting the formation of certain chemicals in the body that mediate pain.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Oral OTC Analgesics Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2020 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Turkey
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Pfizer
  • Bayer
  • Novartis
  • Johnson and Johnson
  • GlaxoSmithKline
  • Sanofi
  • Reckitt Benckiser
  • Takeda Pharmaceutical Company

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2020 to 2027?
  • What will be the industry market growth from 2016 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Oral OTC Analgesics Market, By Product Type, Estimates and Forecast, 2016-2027 ($Million)

o    Acetaminophen (TYLENOL)

o    Salicylates

o    Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

·         Oral OTC Analgesics Market, ByDistribution Channel, Estimates and Forecast, 2016-2027 ($Million)

o    Retail Pharmacies

o    Hospital Pharmacies

o    Online Pharmacies

·         Oral OTC Analgesics Market, By Key Players, Estimates and Forecast, 2016-2027 ($Million)

o    Pfizer

o    Bayer

o    Novartis

o    Johnson and Johnson

o    GlaxoSmithKline

o    Sanofi

o    Reckitt Benckiser

o    Takeda Pharmaceutical Company

·         Oral OTC Analgesics Market, By Region, Estimates and Forecast, 2016-2027 ($Million)

o    North America

§  North America Oral OTC Analgesics Market, By Country

o    U.S. Oral OTC Analgesics Market

o    Canada Oral OTC Analgesics Market

o    Mexico Oral OTC Analgesics Market

o    Europe

§  Europe Oral OTC Analgesics Market, By Country

o    UK Oral OTC Analgesics Market

o    Germany Oral OTC Analgesics Market

o    France Oral OTC Analgesics Market

o    Russia Oral OTC Analgesics Market

o    Italy Oral OTC Analgesics Market

o    Rest of Europe Oral OTC Analgesics Market

o    Asia-Pacific

§  Asia-Pacific Oral OTC Analgesics Market, By Country

o    China Oral OTC Analgesics Market

o    Japan Oral OTC Analgesics Market

o    South Korea Oral OTC Analgesics Market

o    India Oral OTC Analgesics Market

o    Southeast Asia Oral OTC Analgesics Market

o    Rest of Asia-Pacific Oral OTC Analgesics Market

o    South America

§  South America Oral OTC Analgesics Market

o    Brazil Oral OTC Analgesics Market

o    Argentina Oral OTC Analgesics Market

o    Columbia Oral OTC Analgesics Market

o    Rest of South America Oral OTC Analgesics Market

o    Middle East and Africa

§  Middle East and Africa Oral OTC Analgesics Market

o    Saudi Arabia Oral OTC Analgesics Market

o    UAE Oral OTC Analgesics Market

o    Egypt Oral OTC Analgesics Market

o    Nigeria Oral OTC Analgesics Market

o    South Africa Oral OTC Analgesics Market

o    TurkeyOral OTC Analgesics Market

o    Rest of MEA Oral OTC Analgesics Market

 

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2016-2027)

4.1.2.  Canada Market Status and Outlook (2016-2027)

4.1.3.  Mexico Market Status and Outlook (2016-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2016-2027)

4.2.2.  France Market Status and Outlook (2016-2027)

4.2.3.  UK Market Status and Outlook (2016-2027)

4.2.4.  Russia Market Status and Outlook (2016-2027)

4.2.5.  Italy Market Status and Outlook (2016-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2016-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2016-2027)

4.3.2.  Japan Market Status and Outlook (2016-2027)

4.3.3.  Korea Market Status and Outlook (2016-2027)

4.3.4.  India Market Status and Outlook (2016-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2016-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2016-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2016-2027)

4.4.2.  Argentina Market Status and Outlook (2016-2027)

4.4.3.  Columbia Market Status and Outlook (2016-2027)

4.4.4.  Rest of South America Market Status and Outlook (2016-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2016-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2016-2027)

4.5.3.  Egypt Market Status and Outlook (2016-2027)

4.5.4.  Nigeria Market Status and Outlook (2016-2027)

4.5.5.  South Africa Market Status and Outlook (2016-2027)

4.5.6.  Turkey Market Status and Outlook (2016-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2016-2027)

5.       Oral OTC Analgesics  Market, By Product Type

5.1.     Introduction

5.2.     Global Oral OTC Analgesics  Revenue and Market Share by Product Type (2016-2019)

5.2.1.  Global Oral OTC Analgesics  Revenue and Revenue Share by Product Type (2016-2019)

5.3.     Acetaminophen (TYLENOL)

5.3.1.  Global Acetaminophen (TYLENOL) Revenue and Growth Rate (2016-2019)

5.4.     Salicylates

5.4.1.  Global Salicylates Revenue and Growth Rate (2016-2019)

5.5.     Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

5.5.1.  Global Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2019)

6.       Oral OTC Analgesics  Market, By Distribution Channel

6.1.     Introduction

6.2.     Global Oral OTC Analgesics  Revenue and Market Share by Distribution Channel (2016-2019)

6.2.1.  Global Oral OTC Analgesics  Revenue and Revenue Share by Distribution Channel (2016-2019)

6.3.     Retail Pharmacies

6.3.1.  Global Retail Pharmacies Revenue and Growth Rate (2016-2019)

6.4.     Hospital Pharmacies

6.4.1.  Global Hospital Pharmacies Revenue and Growth Rate (2016-2019)

6.5.     Online Pharmacies

6.5.1.  Global Online Pharmacies Revenue and Growth Rate (2016-2019)

7.       Oral OTC Analgesics  Market, By Region

7.1.     Introduction

7.2.     Global Oral OTC Analgesics  Revenue and Market Share by Regions

7.2.1.  Global Oral OTC Analgesics  Revenue by Regions (2016-2019)

7.3.     North America Oral OTC Analgesics  by Countries

7.3.1.  North America Oral OTC Analgesics  Revenue and Growth Rate (2016-2019)

7.3.2.  North America Oral OTC Analgesics  Revenue (Million USD) by Countries (2016-2019)

7.3.3.  United States

7.3.3.1.  United States Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.3.4.  Canada

7.3.4.1.  Canada Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.3.5.  Mexico

7.3.5.1.  Mexico Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.     Europe Oral OTC Analgesics  by Countries

7.4.1.  Europe Oral OTC Analgesics  Revenue and Growth Rate (2016-2019)

7.4.2.  Europe Oral OTC Analgesics  Revenue (Million USD) by Countries (2016-2019)

7.4.3.  Germany

7.4.3.1.  Germany Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.4.  France

7.4.4.1.  France Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.5.  UK

7.4.5.1.  UK Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.6.  Russia

7.4.6.1.  Russia Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.7.  Italy

7.4.7.1.  Italy Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.     Asia-Pacific Oral OTC Analgesics  by Countries

7.5.1.  Asia-Pacific Oral OTC Analgesics  Revenue and Growth Rate (2016-2019)

7.5.2.  Asia-Pacific Oral OTC Analgesics  Revenue (Million USD) by Countries (2016-2019)

7.5.3.  China

7.5.3.1.  China Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.4.  Japan

7.5.4.1.  Japan Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.5.  Korea

7.5.5.1.  Korea Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.6.  India

7.5.6.1.  India Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.     South America Oral OTC Analgesics  by Countries

7.6.1.  South America Oral OTC Analgesics  Revenue and Growth Rate (2016-2019)

7.6.2.  South America Oral OTC Analgesics  Revenue (Million USD) by Countries (2016-2019)

7.6.3.  Brazil

7.6.3.1.  Brazil Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.4.  Argentina

7.6.4.1.  Argentina Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.5.  Columbia

7.6.5.1.  Columbia Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.     Middle East and Africa Oral OTC Analgesics  by Countries

7.7.1.  Middle East and Africa Oral OTC Analgesics  Revenue and Growth Rate (2016-2019)

7.7.2.  Middle East and Africa Oral OTC Analgesics  Revenue (Million USD) by Countries (2016-2019)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.5.  Egypt

7.7.5.1.  Egypt Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.7.  South Africa

7.7.7.1.  South Africa Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.8.  Turkey

7.7.8.1.  Turkey Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2016-2019)

8.       Company Profiles

8.1.     Pfizer

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Bayer

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Novartis

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Johnson and Johnson

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     GlaxoSmithKline

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Sanofi

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Reckitt Benckiser

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Takeda Pharmaceutical Company

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

9.       Oral OTC Analgesics  Market Forecast (2019-2027)

9.1.     Global Oral OTC Analgesics  Revenue (Millions USD) and Growth Rate (2019-2027)

9.2.     Oral OTC Analgesics  Market Forecast by Regions (2019-2027)

9.2.1.  North America Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.1.1.  United States Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.1.2.  Canada Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.1.3.  Mexico Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.2.  Europe Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.2.1.  Germany Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.2.2.  France Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.2.3.  UK Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.2.4.  Russia Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.2.5.  Italy Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.2.6.  Rest of Europe Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.3.  Asia-Pacific Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.3.1.  China Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.3.2.  Japan Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.3.3.  Korea Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.3.4.  India Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.3.5.  Southeast Asia Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.3.6.  Rest of Asia-Pacific Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.4.  South America Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.4.1.  Brazil Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.4.2.  Argentina Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.4.3.  Columbia Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.4.4.  Rest of South America Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.5.  Middle East and Africa Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.5.1.  Saudi Arabia Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.5.2.  United Arab Emirates Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.5.3.  Egypt Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.5.4.  Nigeria Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.5.5.  South Africa Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.5.6.  Turkey Oral OTC Analgesics  Market Forecast (2019-2027)

9.2.5.7.  Rest of Middle East and Africa Oral OTC Analgesics  Market Forecast (2019-2027)

9.3.     Oral OTC Analgesics  Market Forecast by Product Type (2019-2027)

9.3.1.  Oral OTC Analgesics  Forecast by Product Type (2019-2027)

9.3.2.  Oral OTC Analgesics  Market Share Forecast by Product Type (2019-2027)

9.4.     Oral OTC Analgesics  Market Forecast by Distribution Channel (2019-2027)

9.4.1.  Oral OTC Analgesics  Forecast by Distribution Channel (2019-2027)

9.4.2.  Oral OTC Analgesics  Market Share Forecast by Distribution Channel (2019-2027)


List of Tables

List of Tables and Figures:

Figure United States Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Canada Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Mexico Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Germany Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure France Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure UK Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Russia Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Italy Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Europe Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure China Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Japan Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Korea Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure India Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Southeast Asia Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Asia-Pacific Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Brazil Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Argentina Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Columbia Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of South America Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Saudi Arabia Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure United Arab Emirates Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Egypt Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Nigeria Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure South Africa Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Turkey Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Middle East and Africa Oral OTC Analgesics Revenue (Million USD) and Growth Rate (2016-2027)
Table Global Oral OTC Analgesics Revenue and Revenue Share by Product Type (2016-2019)
Figure Global Acetaminophen (TYLENOL) Revenue and Growth Rate (2016-2019)
Figure Global Salicylates Revenue and Growth Rate (2016-2019)
Figure Global Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2019)
Table Global Oral OTC Analgesics Revenue and Revenue Share by Distribution Channel (2016-2019)
Figure Global Retail Pharmacies Revenue and Growth Rate (2016-2019)
Figure Global Hospital Pharmacies Revenue and Growth Rate (2016-2019)
Figure Global Online Pharmacies Revenue and Growth Rate (2016-2019)
Table Global Oral OTC Analgesics Revenue by Regions (2016-2019)
Figure North America Oral OTC Analgesics Growth Rate (2016-2019)
Figure North America Oral OTC Analgesics Revenue and Growth Rate (2016-2019)
Figure North America Oral OTC Analgesics by Countries (2016-2019)
Figure North America Oral OTC Analgesics Revenue (Million USD) by Countries (2016-2019)
Figure United States Oral OTC Analgesics Growth Rate (2016-2019)
Figure United States Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Canada Oral OTC Analgesics Growth Rate (2016-2019)
Figure Canada Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Mexico Oral OTC Analgesics Growth Rate (2016-2019)
Figure Mexico Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Europe Oral OTC Analgesics Growth Rate (2016-2019)
Figure Europe Oral OTC Analgesics Revenue and Growth Rate (2016-2019)
Figure Europe Oral OTC Analgesics by Countries (2016-2019)
Figure Europe Oral OTC Analgesics Revenue (Million USD) by Countries (2016-2019)
Figure Germany Oral OTC Analgesics Growth Rate (2016-2019)
Figure Germany Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure France Oral OTC Analgesics Growth Rate (2016-2019)
Figure France Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure UK Oral OTC Analgesics Growth Rate (2016-2019)
Figure UK Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Russia Oral OTC Analgesics Growth Rate (2016-2019)
Figure Russia Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Italy Oral OTC Analgesics Growth Rate (2016-2019)
Figure Italy Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Europe Oral OTC Analgesics Growth Rate (2016-2019)
Figure Rest of Europe Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Asia-Pacific Oral OTC Analgesics Growth Rate (2016-2019)
Figure Asia-Pacific Oral OTC Analgesics Revenue and Growth Rate (2016-2019)
Figure Asia-Pacific Oral OTC Analgesics by Countries (2016-2019)
Figure Asia-Pacific Oral OTC Analgesics Revenue (Million USD) by Countries (2016-2019)
Figure China Oral OTC Analgesics Growth Rate (2016-2019)
Figure China Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Japan Oral OTC Analgesics Growth Rate (2016-2019)
Figure Japan Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Korea Oral OTC Analgesics Growth Rate (2016-2019)
Figure Korea Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure India Oral OTC Analgesics Growth Rate (2016-2019)
Figure India Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Southeast Asia Oral OTC Analgesics Growth Rate (2016-2019)
Figure Southeast Asia Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Asia-Pacific Oral OTC Analgesics Growth Rate (2016-2019)
Figure Rest of Asia-Pacific Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure South America Oral OTC Analgesics Growth Rate (2016-2019)
Figure South America Oral OTC Analgesics Revenue and Growth Rate (2016-2019)
Figure South America Oral OTC Analgesics by Countries (2016-2019)
Figure South America Oral OTC Analgesics Revenue (Million USD) by Countries (2016-2019)
Figure Brazil Oral OTC Analgesics Growth Rate (2016-2019)
Figure Brazil Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Argentina Oral OTC Analgesics Growth Rate (2016-2019)
Figure Argentina Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Columbia Oral OTC Analgesics Growth Rate (2016-2019)
Figure Columbia Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of South America Oral OTC Analgesics Growth Rate (2016-2019)
Figure Rest of South America Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Middle East and Africa Oral OTC Analgesics Growth Rate (2016-2019)
Figure Middle East and Africa Oral OTC Analgesics Revenue and Growth Rate (2016-2019)
Figure Middle East and Africa Oral OTC Analgesics by Countries (2016-2019)
Figure Middle East and Africa Oral OTC Analgesics Revenue (Million USD) by Countries (2016-2019)
Figure Saudi Arabia Oral OTC Analgesics Growth Rate (2016-2019)
Figure Saudi Arabia Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure United Arab Emirates Oral OTC Analgesics Growth Rate (2016-2019)
Figure United Arab Emirates Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Egypt Oral OTC Analgesics Growth Rate (2016-2019)
Figure Egypt Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Nigeria Oral OTC Analgesics Growth Rate (2016-2019)
Figure Nigeria Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure South Africa Oral OTC Analgesics Growth Rate (2016-2019)
Figure South Africa Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Turkey Oral OTC Analgesics Growth Rate (2016-2019)
Figure Turkey Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Middle East and Africa Oral OTC Analgesics Growth Rate (2016-2019)
Figure Rest of Middle East and Africa Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2016-2019)
Table Pfizer Oral OTC Analgesics Financial Overview
Table Bayer Oral OTC Analgesics Financial Overview
Table Novartis Oral OTC Analgesics Financial Overview
Table Johnson and Johnson Oral OTC Analgesics Financial Overview
Table GlaxoSmithKline Oral OTC Analgesics Financial Overview
Table Sanofi Oral OTC Analgesics Financial Overview
Table Reckitt Benckiser Oral OTC Analgesics Financial Overview
Table Takeda Pharmaceutical Company Oral OTC Analgesics Financial Overview
Figure Global Oral OTC Analgesics Revenue (Millions USD) and Growth Rate (2019-2027)
Table Oral OTC Analgesics Market Forecast by Regions (2019-2027)
Figure North America Oral OTC Analgesics Market Forecast (2019-2027)
Figure United States Oral OTC Analgesics Market Forecast (2019-2027)
Figure Canada Oral OTC Analgesics Market Forecast (2019-2027)
Figure Mexico Oral OTC Analgesics Market Forecast (2019-2027)
Figure Europe Oral OTC Analgesics Market Forecast (2019-2027)
Figure Germany Oral OTC Analgesics Market Forecast (2019-2027)
Figure France Oral OTC Analgesics Market Forecast (2019-2027)
Figure UK Oral OTC Analgesics Market Forecast (2019-2027)
Figure Russia Oral OTC Analgesics Market Forecast (2019-2027)
Figure Italy Oral OTC Analgesics Market Forecast (2019-2027)
Figure Rest of Europe Oral OTC Analgesics Market Forecast (2019-2027)
Figure Asia-Pacific Oral OTC Analgesics Market Forecast (2019-2027)
Figure China Oral OTC Analgesics Market Forecast (2019-2027)
Figure Japan Oral OTC Analgesics Market Forecast (2019-2027)
Figure Korea Oral OTC Analgesics Market Forecast (2019-2027)
Figure India Oral OTC Analgesics Market Forecast (2019-2027)
Figure Southeast Asia Oral OTC Analgesics Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Oral OTC Analgesics Market Forecast (2019-2027)
Figure South America Oral OTC Analgesics Market Forecast (2019-2027)
Figure Brazil Oral OTC Analgesics Market Forecast (2019-2027)
Figure Argentina Oral OTC Analgesics Market Forecast (2019-2027)
Figure Columbia Oral OTC Analgesics Market Forecast (2019-2027)
Figure Rest of South America Oral OTC Analgesics Market Forecast (2019-2027)
Figure Middle East and Africa Oral OTC Analgesics Market Forecast (2019-2027)
Figure Saudi Arabia Oral OTC Analgesics Market Forecast (2019-2027)
Figure United Arab Emirates Oral OTC Analgesics Market Forecast (2019-2027)
Figure Egypt Oral OTC Analgesics Market Forecast (2019-2027)
Figure Nigeria Oral OTC Analgesics Market Forecast (2019-2027)
Figure South Africa Oral OTC Analgesics Market Forecast (2019-2027)
Figure Turkey Oral OTC Analgesics Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Oral OTC Analgesics Market Forecast (2019-2027)
Figure Global Oral OTC Analgesics Forecast by Product Type (2019-2027)
Figure Global Oral OTC Analgesics Market Share Forecast by Product Type (2019-2027)
Figure Global Oral OTC Analgesics Forecast by Product Type (2019-2027)
Figure Global Oral OTC Analgesics Forecast by Distribution Channel (2019-2027)
Figure Global Oral OTC Analgesics Market Share Forecast by Distribution Channel (2019-2027)
Figure Global Oral OTC Analgesics Forecast by Distribution Channel (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*